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Abstract
The World Health Organization (WHO) is revising the tenth version of the International Clas-
sification of Diseases and Related Health Problems (ICD-10). This includes a reconceptuali-
zation of the definition and positioning of Gender Incongruence of Childhood (GIC). This
study aimed to: 1) collect the views of transgender individuals and professionals regarding
the retention of the diagnosis; 2) see if the proposed GIC criteria were acceptable to trans-
gender individuals and health care providers; 3) compare results between two countries
with two different healthcare systems to see if these differences influence opinions regard-
ing the GIC diagnosis; and 4) determine whether healthcare providers from high-income
countries feel that the proposed criteria are clinically useful and easy to use. A total of 628
participants were included in the study: 284 from the Netherlands (NL; 45.2%), 8 from Flan-
ders (Belgium; 1.3%), and 336 (53.5%) from the United Kingdom (UK). Most participants
were transgender people (or their partners/relatives; TG) (n = 522), 89 participants were
healthcare providers (HCPs) and 17 were both HCP and TG individuals. Participants com-
pleted an online survey developed for this study. Overall, the majority response from trans-
gender participants (42.9%) was that if the diagnosis would be removed from the mental
health chapter it should also be removed from the ICD-11 completely, while 33.6% thought it
should remain in the ICD-11. Participants were generally satisfied with other aspects of the
proposed ICD-11 GIC diagnosis: most TG participants (58.4%) thought the term Gender
Identity Disorder should change, and most thought Gender Incongruence was an improve-
ment (63.0%). Furthermore, most participants (76.1%) did not consider GIC to be a psychi-
atric disorder and placement in a separate chapter dealing with Gender and Sexual Health
(the majority response in the NL and selected by 37.5% of the TG participants overall) or as
a Z-code (the majority response in the UK and selected by 26.7% of the TG participants
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overall) would be preferable. In the UK, the majority response (35.8%) was that narrowing
the GIC diagnosis was an improvement, while the NL majority response (49.5%) was that
this was not an improvement. Although generally the results from HCPs were in line with the
results from TG participants some differences were found. This study suggests that,
although in an ideal world a diagnosis is not welcomed, several participants felt the diagno-
sis should not be removed. This is likely due to concerns about restricting access to reim-
bursed healthcare. The choice for positioning of a diagnosis of GIC within the ICD-11 was
as a separate chapter dealing with symptoms and/or disorders regarding sexual and gender
health. This was the overall first choice for NL participants and second choice for UK partici-
pants, after the use of a Z-code. The difference reflects that in the UK, Z-codes carry no neg-
ative implications for reimbursement of treatment costs. These findings highlight the
challenges faced by the WHO in their attempt to integrate research findings from different
countries, with different cultures and healthcare systems in their quest to create a manual
that is globally applicable.
Introduction
The World Health Organization (WHO) is currently revising the tenth version of the Interna-
tional Classification of Diseases and Related Health Problems (ICD-10; [1]). This includes a
reconceptualization of the definition and positioning of the current ICD categories of gender
identity related diagnoses. In many health care systems a diagnosis is required for people to
access the care, including gender-affirming medical treatment [2]. However, including trans-
gender people as part of a diagnostic category can [psycho]pathologize and stigmatize transgen-
der individuals—particularly if these categories remain within the chapter on Mental and
Behavioural Disorders as in the ICD-10. The WHO received a large number of calls to remove
transgender diagnoses from the mental disorders section of the classification system (e.g. of
Global Action for Trans Equality (GATE) [3] and the International Campaign Stop Trans
Pathologization (STP) [4]). The European Parliament also called upon the Commission and the
World Health Organization to withdraw gender identity diagnoses from the mental and beha-
vioural disorders chapter, and to ensure a non-pathologizing reclassification in the ICD-11 [5].
One possible solution that could help to reduce stigma and pathologization of transgender
people would be to include the Gender Incongruence diagnoses, Gender Incongruence of
Adolescence or Adulthood (GIAA) and Gender Incongruence of Childhood (GIC) as Z-codes
(see, for example [3,6]). Z-codes concern “factors influencing health status and contact with
health services” (ICD-10), but do not concern diseases or disorders. Z-codes are used in situa-
tions where something other than a disease, injury or external cause (e.g., poisoning) requires
contact with medical organizations. These are then mentioned as the ’diagnosis’ or ’problem’.
Examples of Z codes include problems related to certain psychological circumstances, such as
unwanted pregnancy; counselling related to sexual attitude, behavior, and orientation; and
psychosocial conditions or problems related to lifestyle or life-management.
One of the proposals for the new ICD is to change the current diagnostic term of Transsexu-
alism to Gender Incongruence (GI) (see [2]). GI would then be included as a Z-code and, rather
than being seen as a disorder or a disease, it would be seen as something that might affect
health. This could help reduce stigma among transgender people, but it may also have disad-
vantages. For example, in some countries, such as the Netherlands, Z-code conditions are not
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reimbursed or covered by health insurers—which would leave many transgender people with-
out access to clinical services. In other countries, such as the United Kingdom, a change to Z-
codes would have no impact on payment for services and their consequent provision. Another
debate related to the new classification system revolves around the diagnosis of Gender Incon-
gruence of Childhood. While some people propose the removal of this diagnosis from the clas-
sification system, others feel that being part of it is important. Proponents for the removal of
this diagnosis state that a diagnosis for children is not needed because: 1) no medical treatment
for pre-pubertal children with gender incongruence of childhood is available (e.g., [3,6]); 2) it
stigmatizes and pathologizes children with normal variations of gender expressions [3,6]; 3)
due to the fact that it is not possible to predict which children will have persisting gender
incongruence of adolescence or adulthood and which will not [7–10], clinical input will be
provided to children when it is not needed thus increasing the risk of iatrogenic harm [6]; and
4) the way gender variance in children is viewed is culture-specific, with many non-Western
cultures being more accepting of gender variance than Western cultures [6].
Proponents for the retention of this diagnosis for children [6] argue that it is required
because: 1) parents will benefit from the help, support and advice associated with it; 2) in
many healthcare systems a diagnosis is needed to access reimbursed care and (specialized)
information; 3) it provides legal protection and a “protected status” (i.e., non-discrimination,
accommodations in school); 4) it facilitates professional training and expertise; and 5) it facili-
tates research to improve the quality of care for children and their families.
In 2013, the World Professional Association for Transgender Health (WPATH) held an
expert consensus meeting to discuss whether the diagnostic category of Gender Incongruence
of Childhood should be removed from the ICD 11 or retained. Consensus was not reached as
votes were equally split with fourteen members voting for removal and fourteen voting for
retention of a diagnosis for children with gender incongruence [6]. A recent survey among
WPATH members concerning the proposed ICD-11 Gender Incongruence of Childhood
diagnosis has had similar results [11].
Proposed changes to the GIC classification
The above mentioned dilemma—regarding how best to provide a classification that ensures
access to care while at the same time providing recognition rather than pathologization or
stigmatization—provided the background to the current proposal of the WHO’s Working
Group on the Classification of Sexual Disorders and Sexual Health (WGSDSH). Several rec-
ommendations relevant to the GIC diagnosis were made by this group (for proposed GIC
criteria see [12]):
1. The diagnosis would no longer be included in the mental health chapter, but be part of an
independent chapter on sexual health.
2. The ICD diagnostic term to be used would be changed from Gender Identity Disorder of
Childhood into Gender Incongruence of Childhood.
3. Stricter criteria for the new diagnosis of GIC would be used in order to reduce the risk of
false positives.
4. Distress due to gender incongruence would not form part of the diagnostic criteria.
The working group noted:
“. . .there are individuals who today present for gender reassignment who may be neither
distressed nor impaired. This may be particularly true for young adolescents who are aware
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of the possibility of gender transition, live in an accepting environment, and who can have
access to puberty suppressing treatments until they are able to take such a decision.” [2]
The WHO published a beta draft of the proposed ICD-11 in order to receive input on the
proposed structure and diagnostic criteria (see [12]). As indicated above, Gender Incongru-
ence of Adolescence and Adulthood and Gender Incongruence of Childhood are placed in the
proposed new chapter entitled ‘Conditions related to sexual health’, which is a deviation from
the preferences for placement of the WGSDSH, whose first preference was for placement in a
separate chapter focused on gender incongruence only [2]. Their second preference was for
the gender incongruence diagnoses to be placed in a new chapter focusing on sexual and gen-
der health [2]. In the current ICD beta version, the focus on gender is lost and reads: Condi-
tions related to Sexual Health, see [12]. The suggested changes concerning placement and
characteristics of the childhood diagnosis were made by the WGSDSH based on the assump-
tion that the diagnosis would remain part of the ICD-11.
Field testing
The WHO has subjected the WGSDSH’s initial recommendations to field testing in a variety
of relevant health care settings in different WHO regions. In all previous revisions, Gender
Incongruence has never been subject to formal field-testing. The WHO has decided that the
new revision should improve clinical utility. WHO views clinical utility as a global public
health issue [13]. Indeed, clinicians consider an important purpose of a diagnostic system to
be a facilitator of communication among clinicians and to inform treatment and management.
Rather than a strict criteria-based approach, clinicians prefer a simple and descriptive system
that can be used by specialists as well as general healthcare providers, in high- as well as mid-
dle- and low-income countries [14].
The WHO is already performing field studies in several low- and middle-income countries
regarding these issues. However, field studies are also necessary in countries with well-devel-
oped healthcare systems, since some of the controversial issues can only be tested in clinical
settings where a sufficient number of patients are assessed. This is particularly the case for chil-
dren and adolescents with gender incongruence, as there are few clinical centres in the world
that are accessible to those children. These are the reasons why the Netherlands and the United
Kingdom (UK) have been selected to undertake these field studies.
The Dutch and UK healthcare systems
Healthcare systems differ across the world, and also between the Netherlands and the United
Kingdom. As the way healthcare is organized might influence ideas about diagnostic classifica-
tion, a short overview of the Dutch and UK systems and the organization of transgender
healthcare is provided. It is mandatory for people who legally live or work in the Netherlands
to have basic healthcare insurance and several insurance providers exist (some for-profit, oth-
ers non-profit) that allow consumers choice during annual open enrolment periods. These
companies are obliged to accept every person for the basic package and are not allowed to
select only people with low health risks (e.g., the young, not having a chronic illness). Discrimi-
nation based on health risks and conditions is therefore not allowed [15]. Consumers may,
however, choose to buy supplemental insurance covering care that is not included in the man-
datory basic insurance. For this supplementary health insurance, insurers are not required to
accept all applicants [16].
Applicants for transgender related healthcare within this system are referred through a gen-
eral practitioner and healthcare reimbursement is based on their diagnosis or that of another
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appropriate professional. Regarding specialist care in the Netherlands, multidisciplinary trans-
gender related healthcare can be obtained at three centres: Leiden University Medical Centre
(children and adolescents), University Medical Centre Groningen (adults), and the Center of
Expertise on Gender Dysphoria (CEGD) of the VU University Medical Centre in Amsterdam
(children, adolescents, and adults). A number of other hospitals do not have multidisciplinary
teams, but do provide transgender related surgery after referral. Aside from this, some trans-
gender people go abroad to obtain surgical interventions, though this is not always reimbursed
by healthcare insurers.
The United Kingdom is made up of four countries (England, Scotland, Wales, and North-
ern Ireland) each of which has a separate National Health Service (NHS) and all of whom use
the ICD-10 [1]. The NHS is funded through central taxation and provides a comprehensive
range of health services, the vast majority of which are free at the point of access for people
legally resident in the United Kingdom. It is not an insurance-based system and although ICD
diagnoses are collected, the funding is not dependent upon them. Therefore diagnoses which
are part of Z-codes are normally funded. Services for adult people (>17 yrs) with gender dys-
phoria who live in England and Wales are funded by NHS England and are provided via seven
NHS Gender Identity Clinic services, all of which are based in England. There is also one Gen-
der Identity Clinic service in Glasgow, Scotland, and one in Belfast, Northern Ireland. The
clinical services were originally developed according to the interests of individual clinicians,
rather than on a national, strategic level, hence the lack of these services in some parts of coun-
try such as the North-West. As in the Netherlands, applicants of transgender related healthcare
are referred through a general practitioner, although clinicians in secondary care services can
also refer. Currently, there is only one NHS service for children and adolescents with gender
dysphoria in the United Kingdom which is based in London, with two satellite clinics in Exeter
and Leeds, England.
Aim of the study
This field study aimed to: 1) collect the views of transgender individuals and professionals
regarding the retention of the diagnosis; 2) see if the proposed GIC criteria were acceptable to
transgender individuals and health care providers 3) compare results between two countries
with two different healthcare systems to see if these differences influence opinions regarding
the GIC diagnosis; and 4) determine whether healthcare providers from high-income coun-
tries feel that the proposed criteria are clinically useful and easy to use.
Methods and Materials
Methodology, sample characteristics, and procedure have been described previously [17],
since data on both the GIC and GIAA diagnosis were collected in one survey.
Methods
Participants & procedure in the Netherlands and Flanders, Belgium (NL). Participants
in this study consisted of healthcare providers as well as consumers of transgender healthcare
and stakeholders (i.e., parents or siblings of transgender children, or partners of transgender
persons). Only people over the age of 16 years were included. Due to the complexity of the
questions, the questionnaire was not suitable for children. Mental health professionals special-
ized in gender incongruence were recruited from the VUmc Center of Expertise on Gender
Dysphoria (CEGD) in Amsterdam, the Netherlands; the Department of Sexology and Gender
of the University Hospital in Ghent in Flanders, Belgium; the Gender team of the University
Medical Center Groningen, the Netherlands; and Transvisie Zorg Amsterdam, the
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Netherlands—an organization that provides information, counselling and psychological care
for transgender people and those in their social environment. Specialized healthcare providers
were sent a link to an online survey to complete. As one of the aims of the WHO is to provide
criteria that are easy to use for health care providers across the world, healthcare providers
who were not specialized in transgender care (e.g., healthcare psychologists, psychiatrists, gen-
eral practitioners, general practitioners trainees, social workers) were recruited to take part as
well. They were contacted via e-mail through the researchers’ networks and after agreeing to
participate were invited via e-mail to the online survey. Furthermore, general psychiatrists and
psychiatric trainees were invited to participate in the survey following a research session orga-
nized by the Dutch researchers. Some participants completed the online version, while others
completed a pen and paper version of the survey. For the recruitment of service users, trans-
gender adults who came to the Vumc Amsterdam Center of Expertise on Gender Dysphoria
(CEGD) for an appointment were asked if they would like to participate in the study. Parents
of transgender children were approached through a mailing of Berdache, a Dutch support
group for parents of transgender children. In addition, parents were approached when they
came to the CEGD at the Vumc. The researchers sent out personal survey links to those inter-
ested in participating.
A total of 758 people were invited to participate in the Dutch survey (from the Netherlands
and Belgium). Of this group, 36 people refused participation for various reasons (multiple
response options were possible): they did not feel like participating (n = 16); they did not have
time (n = 11); it did not matter to them whether or not the diagnosis (terminology and criteria)
was changed (n = 8); and other reasons (n = 5). Ultimately, 722 agreed to participate and
received a link to the survey via e-mail. Despite several reminders, 383 people (53.0%) failed to
open the link to start the survey. At the start of the survey, participants first received informa-
tion about the study and were then asked to give written consent by selecting “yes” in response
to the question: “Do you agree to participate in this study?”. The study was targeted towards
participants who were 16 years or older. No consent was collected from parents or caretakers
for those aged 16 as these younger participants could give consent themselves (in both coun-
tries, the ethics committees agreed with this approach). Forty-one people gave consent but did
not answer any questions so they were removed from the data set. Another 6 participants were
excluded as they answered fewer than 5 questions. A total of 292 Dutch-speaking participants
(284 from the Netherlands, 8 from Belgium) started the survey and answered at least 5 ques-
tions (40.4% of those who received a link to the survey and 38.5% of all participants who were
approached). All participants from Belgium were specialized healthcare providers. The survey
was not presented to transgender people/or their partners or relatives in Belgium. The survey
was completed by 223 people (76.4% of included Dutch participants).
Participants & procedure in the United Kingdom (UK). Researchers at the Nottingham
Centre for Gender Dysphoria (NCGD) contacted 8 Gender Identity Clinic Services in the
United Kingdom and four surgical Centres specialized in transgender surgery, to inform them
of the study and ask for assistance in recruitment and participation. The clinicians at the clin-
ics, including the NCGD, were asked to hand the flyers to their patients and, if possible, give a
brief explanation of the study. Patients were encouraged to share the online link with friends
and family, and clinicians were encouraged to share it with their colleagues within gender and
non-gender specialist services, and it was expected that additional participants would be
recruited via such snowballing methods.
In the UK sample, due to the snowballing method, the number of invitations sent out is
unknown. Overall, 552 UK participants entered the survey. In total, 387 completed the survey
to the end (70.1%) and only their responses were saved by the survey software. Seven partici-
pants did not progress past the information page, but all others continued on to give consent.
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Participants then dropped out at various stages, the greatest drop-outs (n = 71) occurring for
questions regarding the positioning of the diagnosis. Of the 387 participants who completed
the survey in full, 50 were not from the United Kingdom and were excluded. One other person
was excluded because he/she was under the age of 16. This resulted in a final UK sample of 336
participants.
Participants overall. A total of 628 participants were included in data analysis: 292 from
the Netherlands (n = 284) and Flanders, Belgium (n = 8); and 336 (53.5%) from the UK.
Materials
The research team from the Center of Expertise on Gender Dysphoria of the VU University
Medical Center Amsterdam, developed a questionnaire with the input of experts and stake-
holders [17]. This questionnaire covered questions regarding both the Gender Incongruence
of Childhood classification (GIC) and the Gender Incongruence of Adolescence and Adult-
hood (GIAA). The results of the survey questions regarding the GIAA diagnosis are reported
elsewhere, see [17]. The final survey consisted of two parts (see S1 Text for the complete sur-
vey). The first part focused on the view of the service users and clinicians with regard to the
various changes proposed in the ICD-11 (as compared to the ICD-10). A special effort was
made to explain concepts that some participants may have been unfamiliar with through the
use of pop-up information windows accessible via a mouse click on blue-colored, bold and
underlined words. For example, explanations were provided on the concept of a Z-code (this
concerns “factors that affect health and also influence contacts with the healthcare system” but
does not concern diseases or disorders). The second part of the survey was available for health-
care providers only (including transgender participants who were healthcare providers) and
aimed to examine the clinical utility and the clinical implications of the proposed GIC diagno-
sis. The ICD-11 GIC criteria used were the final draft criteria of the WGSDSH (see S2 Text).
The Dutch survey went live on June 2nd 2014 and was open for 10.5 months. For the UK
study, the Dutch version of the questionnaire was translated into English by a Dutch transla-
tion company and then further amendments to the language were made to ensure appropriate-
ness and ease of use by lay people. The questionnaire was then sent to the lead clinicians at all
Gender Identity Clinic services in the United Kingdom, as well as the main providers of gen-
der-related surgery. A meeting took place where stakeholders could comment on the question-
naire and no major amendments were suggested, but the length of the questionnaire was
questioned by various stakeholders. However, changes to this could not be made for reasons of
consistency with the original Dutch version. During the same period, representatives from the
major trans stakeholder groups in the United Kingdom were invited to meet and discuss the
questionnaire in detail. The overarching remit given to this group was to remain as closely as
possible to the original Dutch version of the questionnaire. Amendments were made to some
of the language used, the order of questions, response options, and a small number of new
questions was added. The final version was then translated back into Dutch by another Dutch
translation company and shared with the team in the Netherlands. The online questionnaire
went live in the UK on October 1st 2014 and was open for 7.5 months (see also [17]).
The survey began with a series of demographic questions that asked about age, geographical
location, gender identity (identification and description), birth assigned gender, education,
employment status, and respondent category (i.e., trans, relative, healthcare provider). It then
went on to ask about general opinions towards diagnosis and whether the respondent was
receiving or had received treatment (if applicable). All questions were fixed-choice options,
with spaces provided to answer “other” and add more information if required. The answer
options going through the survey were a mixture of one-option responses or multi-option
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responses, depending upon the question. Options were provided to cover all eventualities,
including neutral/no opinion; always with the addition of “other, please specify” or “please
explain your answer” to allow for additional comments. For example, questions that asked for
level of agreement would give seven main options: “Strongly agree, Agree, Agree a little, Neu-
tral; Neither agree nor disagree, Disagree a little, Disagree, and Strongly disagree”, plus “please
explain your answer”. Questions that asked about opinions (e.g., “Do you think. . ..”) would
give four main options: “Yes, No, No opinion, Don’t know” plus “please explain your answer”
(see also [17]).
The Dutch study was granted full ethical approval (inclusion of Belgian participants and the
consent method for participants under the age of 18 was covered) by the Commissie
Wetenschappelijk Onderzoek [Committee of Scientific Research] of the EMGO Institute for
Health and Care Research (EMGO+) with project ID WC2014-09. The UK study was granted
full ethics approval (the consent method for participants under the age of 18 was covered) by
the UK National Research Ethics Service Committee East Midlands—Nottingham 1 with
IRAS project ID 152591.
Data analysis
Participants who were both healthcare providers and transgender were included in both the
Transgender group (TG) and the Healthcare providers (HCP) group. Differences between par-
ticipants from the United Kingdom (UK) and participants from the Netherlands/Flanders
(NL) were explored with a t-test for continuous data (age), Chi-square tests or Fisher’s Exact
test (for the HCP only questions where the sample was smaller and Chi-square assumptions
were violated) for categorical data and Mann-Whitney U tests for ordinal data or when t-test
assumptions were violated. As participants who were both HCP and TG persons were included
in both groups, the TG and HCP group were not independent. Therefore, no statistical differ-
ences between these groups were explored. The results of the HCP group are described after
the TG group and finally, the findings from the specific questions for healthcare providers are
described.
Results
Sample characteristics
Based on the participant type categories selected (see S3 Text for the additional information on
respondent categories), participants were divided into three categories: healthcare providers
(HCP); service users (transgender persons and their partners and/or relatives; TG); and partic-
ipants who are both healthcare providers and (partners/relatives of) transgender persons. The
TG group consists mainly of transgender persons (see Table A in S3 Text), but also partners,
relatives, and parents of children/adolescents with gender incongruent feelings were included,
as they have first-hand experience with the healthcare provided for their family member. Most
participants were in the TG group (n = 522), 89 participants were HCP, and 17 participants
were both HCP and TG (see Table 1). These three categories were used to analyse the
responses regarding the survey questions. Note that when we refer to the participants from the
Netherlands and Flanders, the abbreviation NL is used.
The age of the participants ranged between 16 years and 78 years with a mean of 38.72 years
(SD = 14.59). There was no statistical difference between the mean age in the Netherlands
(M = 38.47, SD = 13.64, n = 290) and the UK (M = 38.94, SD = 15.38, n = 336), t (624) = -.40,
p = .69). The level of education did not differ between the Netherlands and the UK
(U = 48589.5, p = .81). For sociodemographic characteristics on assigned gender, gender iden-
tity, and level of education see Table 1 below.
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General features of the diagnosis
Terminology. Respondents were asked what they thought of the statement that the ICD-
10 term gender identity disorder should change on a seven point scale (from strongly agree (1)
to strongly disagree (7)). In the TG group (n = 526), the mean agreement was 3.01 (SD = 1.71).
When comparing the responses between the two countries a statistical difference was found
(U = 25259.5, z = -4.66, p< .001, r = -.20). The UK TG participants had a lower score
(M = 2.73, SD = 1.63, n = 319, mean rank = 239.18) than the NL TG participants (M = 3.45,
SD = 1.76, n = 207, mean rank = 300.97), indicating that the UK participants agreed more
strongly with the statement than the NL participants. When the possible responses were
grouped into three categories (agree to various degrees, neutral, disagree to various degrees), it
was found that 64.6% (n = 206) of the UK TG participants, agreed with the statement com-
pared to 48.8% (n = 101) of the NL TG participants. Of the NL participants, 30.4% (n = 63)
reported being neutral compared to 23.2% (n = 74) of the UK participants. In NL 20.8%
(n = 43) and in the UK 12.2% (n = 39) disagreed with the statement. Like the TG participants,
the majority of HCPs (77.7%; n = 80) agreed (to various degrees) with the statement that the
ICD-10 diagnostic term of gender identity disorder should change.
The term gender incongruence (GI) was considered an improvement over the term gender
identity disorder (GID) by 63.0% (n = 201) of the transgender participants in the UK sample
(this question was not present in the Dutch survey), 20.4% (n = 65) did not think the term was
an improvement, 10.3% (n = 33) said it did not matter and the remaining 6.3% (n = 20) had no
opinion. Most healthcare providers from the UK (87.5%; n = 21) also thought GI was an
improvement over GID.
Positioning of the Diagnosis. Of all response options available, when asked where should
the diagnosis go if removed from the mental health chapter, the most frequently selected
option by transgender participants was that it should also be removed from the ICD-11
completely (42.9%; n = 222). Thirty-three point six percent (n = 174) of TG participants
thought the children’s diagnosis should remain in the ICD-11. Nearly a quarter of the partici-
pants had no opinion (20.1%; n = 104) or said it did not matter to them (3.5%; n = 18). There
were statistically significant differences between the countries, (χ2(3) = 9.51, p = .02, Cramer’s
V = .14) (see Table 2). Among healthcare providers, there was mainly support for the retention
of the GIC diagnosis (55.4%; n = 56), while 27.7% (n = 28) of the HCPs wanted to remove GIC
from the ICD-11, 12.9% (n = 13) had no opinion and 4.0% (n = 4) said it did not matter to
them.
Respondents were asked what they thought of the statement that gender incongruence
among children is a psychiatric disorder on a seven point scale (from strongly agree (1) to
strongly disagree (7)). In the TG group (n = 518), the mean (dis)agreement was 5.69
(SD = 1.61). There were no differences between the countries (U = 34362, z = 1.70, p = .10,
Table 2. Frequency Table (and Percentage of Column) of Responses of Transgender Participants to the Question: How would you respond if the
children’s diagnosis for gender incongruence were to be taken out of the chapter on “Psychiatric disorders”? *
Possible response Country of data collection Total (n = 518)
NL (n = 199) UK (n = 319)
It should be removed from the ICD 79 (39.7%) 143 (44.8%) 222 (42.9%)
It should remain in the ICD 66 (33.2%) 108 (33.9%) 174 (33.6%)
No opinion 41 (20.6%) 63 (19.7%) 104 (20.1%)
Doesn’t matter 13 (6.5%) 5 (1.6%) 18 (3.5%)
* Responses on this question differed significantly between the countries, χ2(3) = 9.51, p = .02, Cramer’s V = .14.
doi:10.1371/journal.pone.0168522.t002
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r = .07). The mean score of the UK TG participants (n = 319) was 5.80 (SD = 1.52, mean
rank = 267.72) and 5.51 (SD = 1.72, mean rank = 246.33) for the NL TG participants
(n = 199). When the possible responses were grouped into three categories (agree to various
degrees, neutral, disagree to various degrees), it was found that 76.1% of the TG respondents
(n = 394) disagreed (to various degrees) with the statement, 12.4% (n = 64) were neutral, and
11.6% (n = 60) agreed (to various degrees) with the statement. In line with the results of the
transgender participants, the majority of the HCPs (64.4%; n = 65) disagreed (to various
degrees) with the statement that gender incongruence among children is a psychiatric disor-
der, while 12.9% (n = 13) was neutral and 22.8% (n = 23) agreed.
When asked in which chapter participants thought a diagnosis of gender incongruence for
children should be included, only 7.2% of the transgender participants said that the GIC diag-
nosis should not be in the ICD at all (see Table 3). Over one-third of transgender participants
(37.5%; n = 188) thought the gender incongruence diagnosis for children should be placed in a
separate chapter dealing with symptoms/ disorders regarding sexual and gender health, while
26.7% (n = 134) preferred to include gender incongruence of childhood as a Z-code (see
Table 3 for all responses). The responses differed statistically between the Netherlands and the
UK, (χ2(8) = 38.21, p< .01, Cramer’s V = .28). See Table 3. In the UK, the most frequently
selected option of transgender participants was to include a gender incongruence diagnosis as
a Z-code (32.6%; n = 104) and secondly to place it in a separate chapter dealing with symptoms
and/or disorders regarding sexual and gender health (30.4%; n = 97). Most NL transgender
participants preferred gender incongruence to be placed in a separate chapter dealing with
symptoms and/or disorders regarding sexual and gender health (50.0%; n = 91) and their next
preferred placement was as a Z-code (16.5%; n = 30). In line with the findings for the transgen-
der participants, healthcare providers (40.0%, n = 40) most frequently selected placement in a
separate chapter dealing with symptoms and/or disorders regarding sexual and gender health
and 24.0% (n = 24) preferred to include GIC as a Z-code, while 6.0% (n = 6) thought it should
not be in the ICD at all.
Stigmatization due to a diagnosis
Just over a third (36.6%; n = 188) of transgender participants had no opinion regarding the
question: ‘Do you think that the proposed diagnosis for children will have a greater stigmatizing
effect (i.e. more so than for adults)?’ (see Table 4). Just over a third (34.5%; n = 177) did not
Table 3. Frequency Table (and Percentage of Column) of Responses of Transgender Participants to the Question: In what chapter of the ICD-11
do you think the diagnosis of gender incongruence for children should be included? *
Possible response Country of data collection
NL (n = 182) UK (n = 319) Total (n = 501)
Neurologic disorders and diseases 8 (4.4%) 13 (4.1%) 21 (4.2%)
Hormonal disorders and diseases 8 (4.4%) 18 (5.6%) 26 (5.2%)
Urogenital disorders and diseases 0 (0.0%) 2 (0.6%) 2 (0.4%)
Psychiatric disorders and diseases 11 (6.0%) 5 (1.6%) 16 (3.2%)
It should be part of several medical chapters simultaneously 12 (6.6%) 44 (13.8%) 56 (11.2%)
A separate chapter dealing with symptoms / disorders regarding sexual and gender health 91 (50.0%) 97 (30.4%) 188 (37.5%)
It should be a Z-code 30 (16.5%) 104 (32.6%) 134 (26.7%)
It should not be in the ICD at all 12 (6.6%) 24 (7.5%) 36 (7.2%)
Other, namely 10 (5.5%) 12 (3.8%) 22 (4.4%)
* Responses on this question differed significantly between the countries, χ2(8) = 38.21, p < .01, Cramer’s V = .28.
doi:10.1371/journal.pone.0168522.t003
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think that the proposed diagnosis for children would have a greater stigmatizing effect for chil-
dren than for adults. There was a statistically significant difference between the two countries,
(χ2(3) = 27.91, p< .01, Cramer’s V = .23), see Table 4. Some participants elaborated on this
answer. For example, a Dutch parent who thought the diagnosis did not have a greater stigma-
tizing effect for children than for adults wrote: “When you know something is wrong but cannot
figure out what it is, a diagnosis is a liberation. It is a definition for the problems you are
experiencing. It can be stigmatizing but that doesn’t mean, the diagnosis is bad in itself”. A parent
from the UK wrote: “. . .because again, society still likes to have a doctor’s opinion on anything.
So having a diagnosis will make people take you more seriously. Problem is until you have that
diagnosis. Then everyone looks at you like your kid is only having a tantrum over an extra choco-
late.” Examples of parents who thought a diagnosis would have a greater stigmatizing effect for
children than for adults include: “A diagnosis made (too early) will remain in your medical
record for ever. Even if you are no longer experiencing gender incongruence in puberty. It will
remain a stigma if we are not careful.” (Dutch parent) or “. . .attaching a diagnosis of "incongru-
ence" to a child who is completing a normal process of identity development is premature and
implies that the process of identity development is following an "incongruent" path which does not
match the norm. It is inappropriate to diagnose a condition that will change as the child grows
and matures in their sense of self/identity/esteem” (parent from the UK).
Of the HCPs, just over half (52.5%; n = 53) did not think that the proposed diagnosis for
children would have a greater stigmatizing effect for children than for adults, 26.7% (n = 27)
thought it would and 14.9% (n = 15) had no opinion.
The UK survey included the following question: ‘Do you think having a psychiatric diagnosis
for gender incongruence could have a beneficial effect for children?’. The most commonly
selected response, by a narrow margin, (39.2%; n = 125) was that a psychiatric diagnosis for
gender incongruence would not have a beneficial effect for children. Yet, 32.9% (n = 105) of
participants thought this could have a beneficial effect. The others had no opinion (15.4%;
n = 49) or selected the option ‘Other (please specify). . .’ (12.5%; n = 40).
The results from HCPs differed from those of the TG participants; most HCPs (45.8%;
n = 11) thought that a psychiatric diagnosis for gender incongruence could have a beneficial
effect for children and 25.0% (n = 6) thought it could not.
When asked: ‘Do you think that a child with gender-incongruent feelings needs gender identity
care?’, 78.0% (n = 386) of TG participants agreed with this statement (see Table 5). The
responses differed statistically between the NL and the UK participants, (χ2(2) = 13.99,
p< .01, Cramer’s V = .17), see Table 5. In line with the findings for the transgender partici-
pants, most healthcare providers (58.9%, n = 53) thought that a child with gender-incongruent
feelings needs gender identity care, or were not sure (34.4%, n = 31) while only 6.7% (n = 6)
did not think so.
Table 4. Frequency Table (and Percentage of Column) of Responses of Transgender Participants to the Question: Do you think that the proposed
diagnosis for children will have a greater stigmatising effect (i.e. more so than for adults)? *
Possible response Country of data collection Total (n = 513)
NL (n = 194) UK (n = 319)
No 93 (47.9%) 84 (26.3%) 177 (34.5%)
Yes 40 (20.6%) 82 (25.7%) 122 (23.8%)
No opinion 50 (25.8%) 138 (43.3%) 188 (36.6%)
Other, namely. . . 11 (5.7%) 15 (4.7%) 26 (5.1%)
* Responses on this question differed significantly between the countries, χ2(3) = 27.91, p < .01, Cramer’s V = .23.
doi:10.1371/journal.pone.0168522.t004
GIC - Clinical Utility and Stakeholder Agreement with the Proposed ICD-11 Criteria
PLOS ONE | DOI:10.1371/journal.pone.0168522 January 12, 2017 12 / 20
Stricter criteria of the GIC diagnosis
Responses were mixed regarding the following question: ‘Do you consider it an improvement
that the proposed ICD 11 criteria for the children’s diagnosis will be stricter than in the ICD-10
(children will have to meet all criteria for a period of two years)?’. Slightly more TG participants
(38.2%; n = 189) answered “no” compared to “yes” (33.5%; n = 166) (see Table 6 for all
responses). There were statistically significant differences between UK and NL participants,
(χ2(3) = 105.37, p< .001, Cramer’s V = .46). In the UK, the majority response (35.8%) was
that this was an improvement, while in the NL the majority response (49.5%) was that this was
not an improvement, see Table 6.
Of the HCPs, 46.2% (n = 43) thought the stricter criteria for the diagnosis were an improve-
ment; 18.3% (n = 17) thought it was not; 20.4% (n = 19) was unsure; and 15.1% (n = 14) had
no opinion.
Removal distress and impairment criterion
Most TG participants (combining response options 3 and 4: 60.2%; n = 298) thought it was
desirable if the distress criterion was removed from the children’s diagnosis (see Table 7 for all
responses). Most NL (58.5%; n = 103) and most UK participants (50.2%; n = 160) selected the
option: “Desirable, because for both age groups psychological distress should not be a criterion
for getting a diagnosis.” The response options differed between the countries, so we cannot
make any further comparisons. In line with the findings for the transgender participants, most
healthcare providers (49.5%, n = 45) thought the removal was desirable.
Results from the healthcare provider only questions
There were more HCPs who thought they would able to take care of children (reimbursed by
health care insurance) if there was no children’s diagnosis (n = 22, 26.8%), (taking the two ‘yes’
Table 5. Frequency Table (and Percentage of Column) of Responses of Transgender Participants to the Question: Do you think that a child with
gender-incongruent feelings needs gender identity care? *
Possible response Country of data collection Total (n = 495)
NL (n = 176) UK (n = 319)
No 4 (2.3%) 7 (2.2%) 11 (2.2%)
Yes 153 (86.9%) 233 (73.0%) 386 (78.0%)
I’m not sure, because. . . 19 (10.8%) 79 (24.8%) 98 (19.8%)
* Responses on this question differed significantly between the countries, χ2(2) = 13.99, p < .01, Cramer’s V = .17.
doi:10.1371/journal.pone.0168522.t005
Table 6. Frequency Table (and Percentage of Column) of Responses of Transgender Participants to the Question: Do you consider it an improve-
ment that the proposed ICD 11 criteria for the children’s diagnosis will be stricter than in the ICD 10 (children will have to meet all criteria for a
period of two years)? *
Possible Response Country of data collection Total (n = 495)
NL (n = 176) UK (n = 319)
No 31 (17.6%) 158 (49.5%) 189 (38.2%)
Yes 63 (35.8%) 103 (32.3%) 166 (33.5%)
I’m not sure 54 (30.7%) 7 (2.2%) 61 (12.3%)
No opinion 28 (15.9%) 51 (16.0%) 79 (16.0%)
* Responses on this question differed significantly between the countries, χ2(3) = 105.37, p < .001, Cramer’s V = .46.
doi:10.1371/journal.pone.0168522.t006
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categories together) than HCPs who thought they would not be able to take care of children
(n = 11, 13.4%) (see Table 8). Leaving out the HCPs to whom the question was not applicable
(who did not see children), 51.2% of the participants thought they could provide care for chil-
dren (the two ‘yes’ categories together) and 25.6% thought they could not. The responses to
this question did not differ statistically between the countries (only people to whom the ques-
tion was applicable were included).
Half of the HCPs (50.0%; n = 37) thought the criteria for children were easy to use in their
clinic; 5.4% (n = 4) disagreed; and 44.6% (n = 33) had no opinion. There were no statistically
significant differences between the countries. Furthermore, regarding the duration criterion of
2 years, 39.2% (n = 29) of the HCPs thought it was not difficult to determine whether this crite-
rion was fulfilled; 27.0% (n = 20) thought it was difficult to determine; another 27.0% (n = 20)
had no opinion; and the others (6.8%; n = 5) had another response. There were no statistically
significant differences between the countries. The highest percentage of HCPs (28.8%; n = 21)
thought they could properly make the distinction between slight gender variance and a situa-
tion in which the criteria for the GIC diagnosis have been met; 19.2% (n = 14) thought this
would not be easy; 24.7% (n = 18) had no opinion; and 27.4% (n = 20) did not know. No differ-
ences were found between the countries. Of the Dutch HCPs, 35.8% (n = 19) thought it would
be harder to give a diagnosis if children did not have to express GI feelings than if it were
required to express their feelings; 18.9% (n = 10) thought it would be easier; 26.4% (n = 14)
said it did not matter; and 18.9% (n = 10) had no opinion (NL only question).
Table 7. Frequency Table (and Percentage of Column) of Responses of Transgender Participants to the Question: How do you feel about remov-
ing the distress criterion from the children’s diagnosis (when you think about the children’s diagnosis and the diagnosis for adults)?
Possible Response Country of data collection Total (n = 495)
NL (n = 176) UK (n = 319)
Undesirable, because I consider it important for children and adults that they meet the criterion 20 (11.4%) 33 (10.3%) 53 (10.7%)
Undesirable, because I consider it more important for children that they meet the criterion than for adults 10 (5.7%) 25 (7.8%) 35 (7.1%)
Desirable, because I consider it less important for children that they meet the criterion than for adults 11 (6.3%) 24 (7.5%) 35 (7.1%)
Desirable, because for both age groups psychological distress should not be a criterion for getting a
diagnosis
103 (58.5%) 160 (50.2%) 263 (53.1%)
No opinion 28 (15.9%) 53 (16.6%) 81 (16.4%)
Other, namely (NL only) 4 (2.3%) - -
Undesirable, because. (UK only) - 16 (5.0%) -
Desirable, because. . . (UK only) - 8 (2.5%) -
doi:10.1371/journal.pone.0168522.t007
Table 8. Frequency Table (and Percentage of Column) of Responses of Health Care Providers to the
Question: If no children’s diagnosis existed, would you still be able to treat (and keep treating) chil-
dren who have gender incongruence (reimbursed by health care insurance)? *
Possible response Country of data collection Total (n = 82)
NL (n = 61) UK (n = 21)
Not applicable; I do not assess or treat children 27 (44.3%) 12 (57.1%) 39 (47.6%)
No 6 (9.8%) 5 (23.8%) 11 (13.4%)
Yes, no problem 9 (14.8%) 2 (9.5%) 11 (13.4%)
Yes, but only if I can make another concurrent
diagnosis for it (e.g. depression)
10 (16.4%) 1 (4.8%) 11 (13.4%)
Don’t know 9 (14.8%) 1 (4.8%) 10 (12.2%)
* Responses on this question did not differ significantly between the countries, Fisher’s exact test, p > .05.
doi:10.1371/journal.pone.0168522.t008
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Discussion
This field trial was set up to receive input on WHO’s proposed ICD-11 criteria for Gender
Incongruence of Childhood. A large number of participants were recruited from the Nether-
lands and the United Kingdom and stakeholders from various backgrounds were represented
in the sample, including transgender participants, parents of children with gender incongruent
feelings, healthcare providers (some specialized in transgender health care, others who were
not), and individuals who fit more than one category. The main aim of this study was to iden-
tify whether the GIC diagnosis should be included in the ICD-11. Two questions were asked
regarding the placement of GIC in ICD-11. When asked: How would you respond if the chil-
dren’s diagnosis for gender incongruence (gender dysphoria/gender identity disorder) would
be taken out of the chapter on “psychiatric disorders”?, the most frequently cited response
favoured removing the diagnosis. Healthcare providers were mostly in favour of retaining the
GIC diagnosis within the ICD-11, although about a quarter of them preferred to remove it in
its entirety. This study found more support of healthcare providers for retaining the GIC diag-
nosis in ICD-11, compared to earlier surveys amongst WPATH members (all specialized in
transgender healthcare) where no consensus was reached [6,11], although it should be noted
that the samples differed as our sample consisted of healthcare providers both specialized and
not-specialized in transgender healthcare. Most participants from the UK thought that a psy-
chiatric diagnosis for gender incongruence could not have a beneficial effect for children and a
smaller, but substantial, group disagreed.
The second question was: “In what part of the ICD-11 do you think the diagnosis of gender
incongruence (gender dysphoria/gender identity disorder) for children should be included?”.
In response to this question, most transgender participants chose an option within the ICD-
11, rather than selecting the response option “It should not be in the ICD at all”. Given the
findings above, this appears contradictory, however, this is likely to reflect the participant’s
interpretation of the question. I.e. a participant may favour removal, but if that is not possible,
where would be the next most appropriate place to move it? Similar findings are described
regarding the GI diagnosis in Adolescence/Adulthood [17]. In both cases, the “removal”
response option was the eighth option out of nine and the question does not necessarily imply
that there would be a response option for not being included in the ICD, so some people may
have chosen a category that they found acceptable and may not have finished reading all of the
options. In other words, their responses might have been based on the idea that if the diagnosis
is retained, where they thought the best placement option would be. The number of people in
favour of removing the GIC diagnosis thus might be higher than the percentage of participants
that picked “It should not be in the ICD at all” (7.2%) (see also [17]). Respondents may have
also selected the option of leaving the diagnosis within the ICD as they may see having a diag-
nosis as the only option for accessing clinical services. On the other hand, participants may ini-
tially have favoured removal of the diagnosis (first question), but—after seeing the various
placement options in the second question—they may have considered the removal unneces-
sary and concluded that one of the chapters was an appropriate place for the GIC diagnosis.
Participants were generally satisfied with other aspects of the proposed ICD-11 GIC diagno-
sis. Most transgender participants and stakeholders thought the term Gender Identity Disorder
should change, and most thought Gender Incongruence was an improvement. Furthermore,
most participants reported that they did not consider Gender Incongruence to be a psychiatric
disorder or condition and therefore placement in a separate chapter dealing with Gender and
Sexual Health (the majority response in the Netherlands and in the TG group) or as a Z-code
(the majority response in the UK) would be preferable. It should be noted that the name of the
new chapter was slightly different in the survey (Gender and Sexual Health) than in the current
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beta draft (Sexual Health) [12]. Similar placement preferences were found regarding the Gen-
der Incongruence of Adolescence and Adulthood (GIAA) diagnosis [17]. The differences
between the countries can be at least partially explained by the differences in healthcare sys-
tems described in the introduction of this paper. Including GIC as a Z-code might jeopardize
access to care for Dutch transgender youth. Therefore, this option might be less popular in the
Netherlands than in the United Kingdom, where a Z-code is preferable and access to care is
unaffected by this change in placement. This shows that recognition of the context of existing
healthcare systems within which questions are being answered is important.
WGSDSH’s suggestion to narrow the diagnosis for children in order to reduce the number
of false positives and stigma [2], was not seen as an improvement by a substantial part of the
NL sample (49.5%). However, it was seen as an improvement by 32.3% of the NL sample and
by 35.8% of the UK sample (the majority response in the UK). Furthermore, in relation to
stigma, most transgender participants did not think it was more stigmatizing for children to
receive a GI diagnosis than for adolescents or adults. However, this does not indicate the GIC
diagnosis itself is not stigmatizing.
Most participants thought that a child with gender incongruent feelings needs gender iden-
tity related care. This finding at first sight speaks against the argument that a diagnosis is not
needed because medical treatment for gender incongruence is not available for prepubertal
children (e.g., [3,6]). It is likely that support and psychological input is seen by participants as
useful for children with GIC and their families. Whether or not this type of psychological care
is reimbursed, differs across countries and healthcare systems.
Although generally, the results from healthcare providers were in line with the results from
the transgender participants (and stakeholders) some differences were found. While most
healthcare providers from the UK thought having a psychiatric diagnosis for gender incongru-
ence could have a beneficial effect for children, most transgender participants from the UK
disagreed. Interpretation is difficult since the sample size of the healthcare providers from the
UK was small. Another difference between the participant groups was that most HCPs thought
the stricter GIC criteria to be an improvement, while most TG participants did not. It is inter-
esting that the TG participants have this opinion, as stricter criteria imply that fewer children
with gender incongruence will have a diagnosis and that fewer children would experience the
potential stigmatizing effects of having a diagnosis. Yet TG participants did not support the
stricter criteria and seemed to favour a diagnosis that would include more rather than fewer
children. It may well be that these participants, like many in other quarters, struggle with the
balance between avoiding stigma and access to appropriate care.
Specific questions for healthcare providers (specialized and not-specialized in transgender
related care) showed that they were mainly positive about the proposed children’s diagnosis.
Overall, healthcare providers thought: 1) the GIC criteria were easy to use in their clinic; 2) it
was not difficult to determine whether the duration criterion of experiencing two years of gen-
der incongruence was fulfilled; and 3) the distinction between slight gender variance and a sit-
uation in which the criteria for the diagnosis have been met could be determined properly for
children. One aspect of the proposed GIC diagnosis was seen as more challenging to determine
compared to the ICD-10 criteria: most Dutch HCPs thought the fact that children no longer
have to express or verbalize GI feelings in the proposed ICD-11 made the criteria more diffi-
cult to use than if it were required that they have done so.
Most HCPs thought they could continue providing care for children if there was no GIC
diagnosis. This suggests that most HCPs are not worried about losing access to care for chil-
dren with GI feelings as a result of there not being a diagnosis in ICD-11. However, some
HCPs noted that they could continue to help children only if they could make a concurrent
diagnosis (e.g., depression or anxiety). This suggests that some youth who function well and
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do not have any (mental) health issues might not be able to gain access to care, at least with
these health care professionals. One possibility to ensure access to care is for HCPs to use
deliberate misdiagnosis (for example, to give a child with gender incongruent feelings a diag-
nosis of anxiety). This practice of deliberate misdiagnosis is quite common amongst mental
health professionals [18,19]. Although mental health providers usually do this with the client’s
best interest in mind (e.g., for problems with reimbursement for services if a certain code is
used; or to avoid stigmatizing the patient), clearly this is not ideal and may lead to inaccurate
information on prevalence, policy and program making [18,19], not to mention the ethical
issues involved.
The different views between HCP and transgender participants regarding the need to keep
a GIC diagnosis is likely to be related to the variations in the meaning that a “diagnosis” has
for different people. Classification systems and diagnoses were developed as a means of order-
ing information, grouping phenomena and providing a language by which to communicate
with other clinicians, researchers and patients and their families. It is widely agreed that diag-
nostic criteria should, whenever possible, be based on aetiology. However this is not always
possible. For a researcher a diagnosis might be useful in order to study different phenomena.
Without it, it can make research more complicated, but not impossible. Because of this, clinical
academics may value retaining some kind of diagnosis as part of the classification system.
Transgender people may view things differently. For many years, the psychopathologisation of
transgender people has been linked to its categorization as a psychiatric diagnosis. Transgen-
der people have suffered for many years the discrimination and stigmatisation of being consid-
ered psychiatric patients by clinicians and wider society. Unsurprisingly for transgender
people a diagnosis may always be linked to stigma and removing it all together makes sense.
They may argue that if gay and lesbian people are no longer considered part of a classification
system, why then should transgender people be. For parents of young people with gender
incongruence a diagnosis may be linked to support and advice. Many parents with a child with
gender incongruence may feel isolated and lost. For those parents having somewhere to attend
in order to discuss their distress and concerns is vital. If health services are organised in a way
that a diagnosis is necessary for access, for parents a diagnosis will be linked to support and
help. Parents may suggest keeping a diagnosis in order to have access to services, but is this the
right reason to keep a diagnosis? This survey did not include one of the most difficult questions
to answer: what does a diagnosis mean to you? Future researchers may want to consider this,
as it may help to interpret their findings.
Limitations
Next to the limitations mentioned above regarding the possible influence of the order of
response options, wording of the questions and the low response rate. There are some addi-
tional points to consider also. First, the majority of the transgender participants were individu-
als who intended to receive, were receiving, or had received gender identity care (see S3 Text).
This group may be less opposed to GI diagnoses in ICD-11 since they receive(d) reimbursed
medical treatment made possible (in the NL at least) through a diagnostic code. In other
words, people who want to receive, have received, or are receiving medical care are benefitting
from the presence of a diagnosis because they are eligible for reimbursed health care. As a
result, they might be more positive and less worried about the possible stigmatizing effect of
including GI diagnoses in ICD-11 when compared to transgender people who do not use med-
ical interventions or who have used them a long time ago. It is therefore important to realize
that this study’s sample is not representative of all transgender people in the Netherlands and
the UK (see also [17]).
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A second limitation was that the survey was long and involved some complex concepts
which may have made it difficult to understand for some participants. Indeed, the sample was
biased towards participants with a high level of education. Also, the length of the survey may
have discouraged participants from completing it (see also [17]). Ideally, we would have
included the opinions of the children themselves, but the issues are too complex and abstract
for them to understand, particularly in the context of a long questionnaire. Rather, face-to-face
interviews would have been preferable with young people, but the time and costs associated
with this were prohibitive.
A third limitation specific to this study regarding the Gender Incongruence of Childhood
diagnosis is that we do not know if the adult transgender participants had received a gender
incongruence diagnosis in childhood and have had first-hand experiences with the care pro-
vided and possible negative (e.g. stigmatization) or positive (e.g., access to care and informa-
tion) outcomes of receiving a diagnosis. Such experiences would clearly be important in
shaping opinions regarding the diagnosis.
Conclusion
In conclusion, this study suggests that although in an ideal world a diagnosis relating to gender
incongruence in children is not welcomed, several participants felt the diagnosis should not be
removed. This is likely due to concerns about restricting access to reimbursed healthcare. Fur-
thermore, this study found that the majority choice for positioning of a diagnosis of Gender
Incongruence within the ICD-11 is as a separate chapter dealing with conditions regarding sex-
ual and gender health. This was the overall first choice for participants in The Netherlands and
second choice for those in the UK, behind the use of a Z-code. The difference reflects the fact
that in the UK, Z-codes carry no negative implications of non-reimbursement of treatment
costs. This clearly demonstrates the added layer of complexity that comes with having to con-
sider financial implications and not just psychological, social, and moral ones. These findings
highlight the challenges faced by the WHO in their attempt to integrate research findings from
different countries, with different cultures and healthcare systems and to create a manual that
is globally applicable and usable.
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